Insider trades
Peter Kaiser, Chief Officer of Ocular Therapeutix OCUL, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $190.2K. The latest trade was on 05/26.
Peter Kaiser
Chief Development Officer
- Company
- Ocular Therapeutix OCUL
- First filing
- 24/10/04
- Trades
- 12 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- −$190.2K
- Last trade
- 05/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 05/26 | 05/28 | 2,967 sh | $8.20 | $24,329.4 | −1.1% | |
| Open-market sale10b5-1 plan | 02/23 | 02/25 | 2,810 sh | $8.28 | $23,266.8 | −1.0% | |
| Open-market sale10b5-1 plan | 25/11/24 | 25/11/26 | 3,007 sh | $12.02 | $36,144.14 | −1.5% | |
| Open-market sale10b5-1 plan | 25/10/02 | 25/10/06 | 9,653 sh | $11.03 | $106,472.59 | −4.7% | |
| Open-market sale10b5-1 plan | 25/08/25 | 25/08/27 | 3,011 sh | $12.04 | $36,252.44 | −1.5% | |
| Open-market sale10b5-1 plan | 25/05/23 | 25/05/27 | 2,974 sh | $7.17 | $21,323.58 | −1.4% | |
| Open-market sale10b5-1 plan | 25/02/24 | 25/02/26 | 3,009 sh | $6.87 | $20,671.83 | −1.4% | |
| Open-market sale10b5-1 plan | 24/11/25 | 24/11/27 | 2,897 sh | $9.01 | $26,101.97 | −1.3% |